ArticleGynecologic oncology2019

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade.

Julia L Boland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.